Helene Roelofs

9.5k total citations · 2 hit papers
76 papers, 7.2k citations indexed

About

Helene Roelofs is a scholar working on Genetics, Hematology and Surgery. According to data from OpenAlex, Helene Roelofs has authored 76 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 25 papers in Hematology and 22 papers in Surgery. Recurrent topics in Helene Roelofs's work include Mesenchymal stem cell research (45 papers), Hematopoietic Stem Cell Transplantation (23 papers) and Tissue Engineering and Regenerative Medicine (11 papers). Helene Roelofs is often cited by papers focused on Mesenchymal stem cell research (45 papers), Hematopoietic Stem Cell Transplantation (23 papers) and Tissue Engineering and Regenerative Medicine (11 papers). Helene Roelofs collaborates with scholars based in Netherlands, Italy and Sweden. Helene Roelofs's co-authors include Willem E. Fibbe, Maria Ester Bernardo, Franco Locatelli, Lynne M. Ball, R. Maarten Egeler, Jaap Jan Zwaginga, Sara M. Melief, Katarina Le Blanc, Francesco Frassoni and Olle Ringdén and has published in prestigious journals such as The Lancet, Blood and Gastroenterology.

In The Last Decade

Helene Roelofs

75 papers receiving 7.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

2008 2.0k citations Katarina Le Blanc, Francesco Frassoni et al. profile →
Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts

2013 339 citations Sara M. Melief, Jaap Jan Zwaginga et al. Stem Cells Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helene Roelofs Netherlands	35	5.0k	2.6k	1.8k	1.2k	1.2k	76	7.2k
Luc Sensebé France	45	5.3k 1.1×	2.9k 1.1×	2.6k 1.5×	815 0.7×	762 0.6×	131	8.7k
Pierre Charbord France	45	3.8k 0.8×	1.8k 0.7×	2.6k 1.5×	1.3k 1.1×	919 0.8×	147	7.9k
Maria Ester Bernardo Italy	41	5.4k 1.1×	2.4k 0.9×	2.8k 1.6×	2.3k 1.9×	1.9k 1.5×	109	9.7k
Mehmet Uzunel Sweden	34	3.6k 0.7×	1.6k 0.6×	1.3k 0.7×	2.1k 1.7×	1.5k 1.2×	78	6.2k
Ida Rasmusson Sweden	10	4.2k 0.8×	1.8k 0.7×	1.2k 0.6×	1.1k 0.9×	884 0.7×	11	5.0k
Cecilia Götherström Sweden	25	3.9k 0.8×	1.9k 0.7×	1.5k 0.8×	773 0.6×	711 0.6×	63	5.3k
Mauro Krampera Italy	47	6.7k 1.4×	3.3k 1.2×	3.3k 1.9×	1.2k 1.0×	1.9k 1.6×	160	11.1k
Volker Eckstein Germany	37	2.9k 0.6×	1.3k 0.5×	2.2k 1.2×	1.4k 1.1×	1.2k 1.0×	121	6.4k
Berit Sundberg Sweden	33	7.6k 1.5×	4.1k 1.5×	2.3k 1.3×	2.7k 2.2×	1.8k 1.5×	95	10.9k
Mara Riminucci Italy	45	3.7k 0.8×	1.9k 0.7×	3.2k 1.8×	1.0k 0.8×	533 0.4×	174	10.0k

Countries citing papers authored by Helene Roelofs

Since Specialization

Citations

This map shows the geographic impact of Helene Roelofs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helene Roelofs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helene Roelofs more than expected).

Fields of papers citing papers by Helene Roelofs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helene Roelofs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helene Roelofs. The network helps show where Helene Roelofs may publish in the future.

Co-authorship network of co-authors of Helene Roelofs

This figure shows the co-authorship network connecting the top 25 collaborators of Helene Roelofs. A scholar is included among the top collaborators of Helene Roelofs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helene Roelofs. Helene Roelofs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tienen, Florence H. J. van, Janneke G. J. Hoeijmakers, Christiaan van der Leij, et al.. (2025). Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1/2 human clinical study. Molecular Therapy. 33(10). 5061–5072.

Reinders, Marlies E. J., Sanne H. Hendriks, Aiko P. J. de Vries, et al.. (2021). Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study. American Journal of Transplantation. 21(9). 3055–3065. 30 indexed citations

Heidt, Sebastiaan, Dave L. Roelen, Melissa van Pel, et al.. (2020). Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study. American Journal of Transplantation. 20(10). 2905–2915. 34 indexed citations

Roelofs, Helene, et al.. (2016). Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients. ERJ Open Research. 2(2). 45–2015. 14 indexed citations

Garde, Mark van der, Melissa van Pel, Manon C. Slot, et al.. (2015). Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34 ⁺ Transplants. Stem Cells and Development. 24(22). 2649–2659. 22 indexed citations

Roelofs, Helene, et al.. (2015). Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion. SpringerPlus. 4(1). 336–336. 17 indexed citations

Reinders, Marlies E. J., Johan W. de Fijter, Helene Roelofs, et al.. (2013). Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction. American Journal of Transplantation. 13. 340–340. 1 indexed citations

Melief, Sara M., Jaap Jan Zwaginga, Willem E. Fibbe, & Helene Roelofs. (2013). Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts. Stem Cells Translational Medicine. 2(6). 455–463. 339 indexed citations breakdown →

Calkoen, Friso, Cornelia M. Jol‐van der Zijde, M. Luisa Mearin, et al.. (2013). Gastrointestinal Acute Graft-versus-Host Disease in Children: Histology for Diagnosis, Mesenchymal Stromal Cells for Treatment, and Biomarkers for Prediction of Response. Biology of Blood and Marrow Transplantation. 19(11). 1590–1599. 12 indexed citations

10.

Torensma, Ruurd, Henk‐Jan Prins, Ellen Schrama, et al.. (2012). The Impact of Cell Source, Culture Methodology, Culture Location, and Individual Donors on Gene Expression Profiles of Bone Marrow-Derived and Adipose-Derived Stromal Cells. Stem Cells and Development. 22(7). 1086–1096. 39 indexed citations

11.

Maijenburg, Marijke W., Christian Gilissen, Sara M. Melief, et al.. (2011). Nuclear Receptors Nur77 and Nurr1 Modulate Mesenchymal Stromal Cell Migration. Stem Cells and Development. 21(2). 228–238. 56 indexed citations

12.

Duijvestein, Marjolijn, Ilse Molendijk, Helene Roelofs, et al.. (2011). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 13(9). 1066–1073. 40 indexed citations

13.

Ball, L.M., Maria Ester Bernardo, Maarten J. D. van Tol, et al.. (2011). Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children. Bone Marrow Transplantation. 46. 1 indexed citations

14.

Ball, L.M., Maria Ester Bernardo, Maarten J. D. van Tol, et al.. (2010). Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation. Bone Marrow Transplantation. 45. 1 indexed citations

15.

Duijvestein, Marjolijn, Anne Christine W. Vos, Helene Roelofs, et al.. (2010). Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut. 59(12). 1662–1669. 488 indexed citations

16.

Jansen, Bas, Christian Gilissen, Helene Roelofs, et al.. (2009). Functional Differences Between Mesenchymal Stem Cell Populations Are Reflected by Their Transcriptome. Stem Cells and Development. 19(4). 481–490. 114 indexed citations

17.

Borghans, José A. M., Robbert G. M. Bredius, Mette D. Hazenberg, et al.. (2006). Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency. Blood. 108(2). 763–769. 56 indexed citations

18.

Leigh, Don, et al.. (2000). Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. British Journal of Cancer. 83(6). 729–736. 42 indexed citations

19.

Roelofs, Helene, et al.. (1999). グルタチオンS-トランスフェラーゼP1遺伝子の多形性と,Barrett食道および食道癌の発症感受性との関連性. Cancer Research. 59(3). 586–589. 9 indexed citations

20.

Tlsty, Thea D., Anne White, Elizabeth Livanos, et al.. (1994). Genomic Integrity and the Genetics of Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 265–275. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact